High induction rate onto extended-release naltrexone for people with opioid use disorder: experiences from a Norwegian naturalistic study

Abstract Background For people with opioid use disorder (OUD), extended-release naltrexone (XR-NTX) is an effective antagonist treatment option. However, successful opioid tapering and abstinence is a prerequisite for XR-NTX induction and has repeatedly been reported as a major barrier to effective...

Full description

Saved in:
Bibliographic Details
Main Authors: Jon Mordal, Farid Juya, Line Holtan, John-Kåre Vederhus, Arild Opheim, Ida H. Brenna, Asle E. Enger, Bente Weimand, Kristin Klemmetsby Solli, Lars Tanum
Format: Article
Language:English
Published: BMC 2025-06-01
Series:Addiction Science & Clinical Practice
Subjects:
Online Access:https://doi.org/10.1186/s13722-025-00576-9
Tags: Add Tag
No Tags, Be the first to tag this record!